The Nuclear Transcription Factor B/BCL-2 Pathway Correlates With Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-0885
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2005
Authors
Publisher
American Association for Cancer Research (AACR)